Zobrazeno 1 - 10
of 230
pro vyhledávání: '"Reardon, David"'
Autor:
Latzer P; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Zelba H; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Battke F; CeGaT GmbH, Tübingen, Germany., Reinhardt A; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Shao B; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Bartsch O; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Rabsteyn A; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Harter J; CeGaT GmbH, Tübingen, Germany., Schulze M; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Okech T; MVZ Zentrum für ambulante Onkologie GmbH, Tübingen, Germany., Golf A; MVZ Zentrum für ambulante Onkologie GmbH, Tübingen, Germany., Kyzirakos-Feger C; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Kayser S; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Pieper N; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Feldhahn M; CeGaT GmbH, Tübingen, Germany., Wünsche J; Zentrum für Humangenetik Tübingen, Tübingen, Germany.; MVZ Zentrum für ambulante Onkologie GmbH, Tübingen, Germany., Seitz C; Universitätsklinikum Heidelberg, KiTZ, Hopp Children's Cancer Center, Heidelberg, Germany., Hadaschik D; CeCaVa GmbH, Tübingen, Germany., Garbe C; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany., Hauser TK; Department für Radiologie, Universitätsklinikum Tübingen, Tübingen, Germany., la Fougère C; Nuklearmedizin und Klinische Molekulare Bildgebung, Universitätsklinikum Tübingen, Tübingen, Germany., Biskup D; CeGaT GmbH, Tübingen, Germany., Brooke D; Provenance Precision Medicine Foundation, Wilmette, IL, USA., Parker D; PHM, Los Angeles, CA, USA., Martens UM; Department of Hematology and Oncology, Cancer Center Heilbronn-Franken, SLK Kliniken GmbH, Heilbronn, Germany., Illerhaus G; Klinikum Stuttgart, Stuttgart, Germany., Blumenthal DT; Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel Aviv, Israel., Merrell R; Vanderbilt University Medical Center, Nashville, TN, USA., Lorenzo LS; Clínica Universidad de Navarra, Madrid, Spain., Hidvégi M; Jewish Theological Seminary-University of Jewish Studies (OR-ZSE), Budapest, Hungary., de Robles P; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.; Tom Baker Cancer Centre, Calgary, AB, Canada., Kebir S; Universitätsklinikum Essen, Essen, Germany., Li WW; Angiogenesis Foundation, Cambridge, MA, USA., Li VW; Angiogenesis Foundation, Cambridge, MA, USA.; Harvard Medical School Dermatology, Boston, MA, USA., Williams M; NHS London, London, UK., Miller AM; Brain and Spine Tumor Center, NYU Langone Health's Perlmutter Cancer Center, New York, NY, USA., Kesari S; Pacific Neuroscience Institute, Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA., Castro M; Cellworks Group Inc, South San Francisco, CA, USA.; Personalized Cancer Medicine, PLLC, Santa Monica, CA, USA., Desjardins A; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Ashley DM; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.; Preston Robert Tisch Brain Tumor Centre, Duke University, Durham, NC, USA., Friedman HS; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Neil EC; Department of Neurology, University of Minnesota Health, Minneapolis, MN, USA., Iwamoto FM; Columbia University Medical Center, New York, NY, USA., Sipos B; BAG für Pathologie und Molekularpathologie Stuttgart, Molekularpathologie Baden-Württemberg GbR, Stuttgart, Germany., Geletneky K; Klinikum Darmstadt GmbH, Darmstadt, Germany., Zender L; University Hospital Tübingen, Internal Medicine VIII, Tübingen, Germany., Glas M; Division of Clinical Neurooncology, Department of Neurology, Universitätsklinikum Essen Klinik für Neurologie, Essen, Germany., Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Biskup S; Zentrum für Humangenetik Tübingen, Tübingen, Germany. Saskia.Biskup@humangenetik-tuebingen.de.; CeGaT GmbH, Tübingen, Germany. Saskia.Biskup@humangenetik-tuebingen.de.
Publikováno v:
Nature communications [Nat Commun] 2024 Aug 11; Vol. 15 (1), pp. 6870. Date of Electronic Publication: 2024 Aug 11.
Autor:
McDannold N; Department of Radiology, Brigham and Women's Hospital, Boston, MA, United States of America. Electronic address: njm@bwh.harvard.edu., Wen PY; Department of Neuro-oncology, Dana Farber Cancer Institute, Boston, MA, United States of America., Reardon DA; Department of Neuro-oncology, Dana Farber Cancer Institute, Boston, MA, United States of America., Fletcher SM; Department of Radiology, Brigham and Women's Hospital, Boston, MA, United States of America., Golby AJ; Department of Radiology, Brigham and Women's Hospital, Boston, MA, United States of America; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, United States of America.
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2024 Aug; Vol. 372, pp. 194-208. Date of Electronic Publication: 2024 Jun 21.
Autor:
Wan Q; Department of Imaging, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Radiology, the Key Laboratory of Advanced Interdisciplinary Studies Center, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Kim J; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Lindsay C; Image Processing and Analysis Core (iPAC), Department of Radiology, University of Massachusetts Chan Medical School, Worcester, MA, USA., Chen X; School of Medicine, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, Guangdong, China., Li J; Department of Radiology, the Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou, China., Iorgulescu JB; Molecular Diagnostics Laboratory, Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA., Huang RY; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Zhang C; Digital Medical Research Center, School of Basic Medical Sciences, Fudan University, Shanghai, China., Reardon D; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Young GS; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. gsyoung@bwh.harvard.edu., Qin L; Department of Imaging, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. lei_qin@dfci.harvard.edu.
Publikováno v:
Journal of imaging informatics in medicine [J Imaging Inform Med] 2024 Aug; Vol. 37 (4), pp. 1401-1410. Date of Electronic Publication: 2024 Feb 21.
Autor:
Lim-Fat MJ; Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada., Iorgulescu JB; Molecular Diagnostics Laboratory, Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Rahman R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Bhave V; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Muzikansky A; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts., Woodward E; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Whorral S; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Allen M; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Touat M; Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France., Li X; Shandong University, Jinan, China., Xy G; Shandong University, Jinan, China., Patel J; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts., Gerstner ER; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts., Kalpathy-Cramer J; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts., Youssef G; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Chukwueke U; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., McFaline-Figueroa JR; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Nayak L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Beroukhim R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Huang RY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Ligon KL; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Apr 01; Vol. 30 (7), pp. 1327-1337.
Autor:
Chen E; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Ling AL; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Chiocca EA; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2024 Feb 02; Vol. 26 (2), pp. 211-225.
Autor:
Tobochnik S; Department of Neurology, VA Boston Healthcare System, Boston, Massachusetts, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Dorotan MKC; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Ghosh HS; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Lapinskas E; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Vogelzang J; Department of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Reardon DA; Department of Medical Oncology, Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Ligon KL; Department of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Smirnakis SM; Department of Neurology, VA Boston Healthcare System, Boston, Massachusetts, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Lee JW; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2024 Feb 02; Vol. 26 (2), pp. 323-334.
Autor:
Rahman R; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Trippa L; Dana-Farber Cancer Institute, Boston, MA., Lee EQ; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Arrillaga-Romany I; Massachusetts General Hospital, Boston, MA., Fell G; Dana-Farber Cancer Institute, Boston, MA., Touat M; Brigham and Women's Hospital, Boston, MA.; Sorbonne Universite, Hôpitaux Universitaires La Pitié Salpêtrière, Paris, France., McCluskey C; Dana-Farber Cancer Institute, Boston, MA., Wiley J; Dana-Farber Cancer Institute, Boston, MA., Gaffey S; Dana-Farber Cancer Institute, Boston, MA., Drappatz J; University of Pittsburgh, Pittsburgh, PA., Welch MR; Division of Neuro-Oncology, Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian, New York, NY., Galanis E; Mayo Clinic, Rochester, MN., Ahluwalia MS; Miami Cancer Institute, Miami, FL., Colman H; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Nabors LB; University of Alabama at Birmingham, Birmingham, AL., Hepel J; Rhode Island Hospital, Providence, RI., Elinzano H; Rhode Island Hospital, Providence, RI., Schiff D; University of Virginia, Charlottesville, VA., Chukwueke UN; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Beroukhim R; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Nayak L; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., McFaline-Figueroa JR; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Batchelor TT; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Rinne ML; Dana-Farber Cancer Institute, Boston, MA., Kaley TJ; Memorial Sloan Kettering Cancer Center, New York, NY., Lu-Emerson C; Maine Medical Center, Portland, ME., Mellinghoff IK; Memorial Sloan Kettering Cancer Center, New York, NY., Bi WL; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Arnaout O; Brigham and Women's Hospital, Boston, MA., Peruzzi PP; Brigham and Women's Hospital, Boston, MA., Haas-Kogan D; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Tanguturi S; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Cagney D; Mater Private, Dublin, Ireland., Aizer A; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Doherty L; Dana-Farber Cancer Institute, Boston, MA., Lavallee M; Dana-Farber Cancer Institute, Boston, MA., Fisher-Longden B; Dana-Farber Cancer Institute, Boston, MA., Dowling S; Dana-Farber Cancer Institute, Boston, MA., Geduldig J; Dana-Farber Cancer Institute, Boston, MA., Watkinson F; Dana-Farber Cancer Institute, Boston, MA., Pisano W; Dana-Farber Cancer Institute, Boston, MA., Malinowski S; Dana-Farber Cancer Institute, Boston, MA., Ramkissoon S; Dana-Farber Cancer Institute, Boston, MA., Santagata S; Brigham and Women's Hospital, Boston, MA., Meredith DM; Brigham and Women's Hospital, Boston, MA., Chiocca EA; Brigham and Women's Hospital, Boston, MA., Reardon DA; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Alexander BM; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Ligon KL; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Wen PY; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Dec 20; Vol. 41 (36), pp. 5524-5535. Date of Electronic Publication: 2023 Sep 18.
Autor:
Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA., van den Bent M; Department Neuro-Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Youssef G; Center for Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA., Cloughesy TF; UCLA Brain Tumor Program, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA., Ellingson BM; UCLA Brain Tumor Imaging Laboratory, Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA., Weller M; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland., Galanis E; Mayo Clinic, Department of Oncology, Rochester, MN., Barboriak DP; Department of Radiology, Duke University Medical Center, Durham, NC., de Groot J; Division of Neuro-Oncology, Department of Neurosurgery, University of California, San Francisco, CA., Gilbert MR; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Huang R; Division of Neuro-radiology, Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA., Lassman AB; Division of Neuro-Oncology, Department of Neurology, Herbert Irving Comprehensive Cancer Center and Irving Institute for Clinical and Translational Research, Columbia University Vagelos College of Physicians and Surgeons and New York-Presbyterian Hospital, New York, NY., Mehta M; Miami Cancer Institute, Miami, FL., Molinaro AM; Division of Biomedical Statistics and Informatics, Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA., Preusser M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Rahman R; Department of Radiation Oncology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA., Shankar LK; Clinical Trials Branch, Cancer Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD., Stupp R; Malnati Brain Tumor Institute, Lurie Comprehensive Cancer Center and Departments of Neurological Surgery, Neurology and Division of Hematology/Oncology, Northwestern University, Chicago, IL., Villanueva-Meyer JE; Departments of Radiology and Neurosurgery, University of California San Francisco, San Francisco, CA., Wick W; Department of Neurology Heidelberg University Hospital & Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Macdonald DR; Departments of Clinical Neurological Sciences and Oncology (Emeritus), Western University, London, Ontario, Canada., Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA., Vogelbaum MA; Departments of Neuro-Oncology and Neurosurgery, Moffitt Cancer Center, Tampa, FL., Chang SM; Division of Neuro-Oncology, Department of Neurosurgery, University of California, San Francisco, CA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Nov 20; Vol. 41 (33), pp. 5187-5199. Date of Electronic Publication: 2023 Sep 29.
Autor:
Ling AL; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Solomon IH; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Landivar AM; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Nakashima H; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Woods JK; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Santos A; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Masud N; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Fell G; Department of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA., Mo X; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA.; James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA., Yilmaz AS; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA.; James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA., Grant J; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Zhang A; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Bernstock JD; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Torio E; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Ito H; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Liu J; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Shono N; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Nowicki MO; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Triggs D; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Halloran P; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Piranlioglu R; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Soni H; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Stopa B; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Bi WL; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Peruzzi P; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Chen E; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Malinowski SW; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Prabhu MC; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Zeng Y; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Carlisle A; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wen PY; Center for Neuro-oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lee EQ; Center for Neuro-oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Nayak L; Center for Neuro-oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Chukwueke U; Center for Neuro-oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Gonzalez Castro LN; Center for Neuro-oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA., Dumont SD; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Batchelor T; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA., Kittelberger K; ClearPoint Neuro, Solana Beach, CA, USA., Tikhonova E; BostonGene, Waltham, MA, USA., Miheecheva N; BostonGene, Waltham, MA, USA., Tabakov D; BostonGene, Waltham, MA, USA., Shin N; BostonGene, Waltham, MA, USA., Gorbacheva A; BostonGene, Waltham, MA, USA., Shumskiy A; BostonGene, Waltham, MA, USA., Frenkel F; BostonGene, Waltham, MA, USA., Aguilar-Cordova E; Candel Therapeutics, Needham, MA, USA., Aguilar LK; Candel Therapeutics, Needham, MA, USA., Krisky D; Candel Therapeutics, Needham, MA, USA., Wechuck J; Candel Therapeutics, Needham, MA, USA., Manzanera A; Candel Therapeutics, Needham, MA, USA., Matheny C; Candel Therapeutics, Needham, MA, USA., Tak PP; Candel Therapeutics, Needham, MA, USA., Barone F; Candel Therapeutics, Needham, MA, USA., Kovarsky D; Department of Molecular Cell Biology, Weizmann Institute of Medical Sciences, Tel Aviv, Israel., Tirosh I; Department of Molecular Cell Biology, Weizmann Institute of Medical Sciences, Tel Aviv, Israel., Suvà ML; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana Farber Cancer Institute, Boston, MA, USA., Ligon K; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Reardon DA; Center for Neuro-oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Chiocca EA; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA. eachiocca@bwh.harvard.edu.
Publikováno v:
Nature [Nature] 2023 Nov; Vol. 623 (7985), pp. 157-166. Date of Electronic Publication: 2023 Oct 18.
Autor:
Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. david_reardon@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, USA. david_reardon@dfci.harvard.edu., Cahill DP; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurosurgery, Harvard Medical School, Boston, MA, USA.
Publikováno v:
Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2023 Nov; Vol. 20 (11), pp. 737-738.